TY  - JOUR
AU  - Martinez-Esteban, Maria Dolores
AU  - Vazquez-Sanchez, Teresa
AU  - Pozo-Alvarez, Rafael
AU  - Moreno-Ortiz, Alicia
AU  - Alonso-Titos, Juana
AU  - Martin-Reyes, Guillermo
AU  - Ruiz-Esteban, Pedro
AU  - Gaitan-Roman, Daniel
AU  - Hernandez, Domingo
PY  - 2022
DO  - 10.1186/s12882-022-02919-z
UR  - http://hdl.handle.net/10668/20272
T2  - BMC nephrology
AB  - The association between cardiac complications, such as heart failure (HF), and chronic kidney disease (CKD) is well known. In this study, we examined the effectiveness and safety of treatment with neprilysin inhibition in patients with advanced...
LA  - en
PB  - BioMed Central
KW  - Chronic kidney disease
KW  - Glomerular filtration rate
KW  - Heart failure
KW  - Neprilysin inhibitor
KW  - Reduced ejection fraction
KW  - Aged
KW  - Aminobutyrates
KW  - Biphenyl Compounds
KW  - Drug Combinations
KW  - Heart Failure
KW  - Humans
KW  - Renal Insufficiency, Chronic
KW  - Retrospective Studies
KW  - Stroke Volume
KW  - Valsartan
KW  - Ventricular Function, Left
TI  - Cardio-renal benefits of sacubitril/valsartan in patients with advanced chronic kidney disease: experience in daily clinical practice.
TY  - research article
VL  - 23
ER  -